Recent Advances in the Treatment of Advanced HER2+ Breast Cancer: SABCS 2024 - Episode 8
Precision in CNS Targeting: Optimizing Management of Brain Metastases in HER2+ Breast Cancer
Panelists discuss how treatment selection for patients with HER2+ breast cancer with brain metastases requires careful consideration of factors such as metastatic burden, symptomatology, and prior therapies, typically incorporating both local approaches and systemic agents with CNS activity while accounting for individual patient characteristics such as performance status, comorbidities, and preferences in developing personalized treatment plans.
Video content above is prompted by the following:
Briefly discuss how you approach treatment for patients with HER2+ advanced breast cancer with brain metastases.
a. How do you select among available therapies and what factors drive your overall strategy?
b. Are there factors that may lead you to deviate from your standard approach?
c. What challenges do you face in treating this patient population, and what unmet needs remain?
Related Content:
